BioFocus provides integrated drug discovery that delivers pre-clinical drug candidates in all therapeutic areas with strong capability in neurodegenerative diseases, inflammatory diseases and with a growing track record of delivering candidates against rare and neglected diseases.
News, events and newsletters
New at BioFocus
New at BioFocus: Automated patch-clamp assay for assessment of hERG liability. Using our electrophysiology expertise, BioFocus has validated a hERG inhibition assay combining the IonWorks® Quattro™ automated electrophysiology platform, with the PrecisION™ hERG-HEK recombinant cell line from Millipore.
Contact us now for a quotation.